Crystal-induced neutrophil activation

Immunology and Cell Biology

Volumn 88, Issue 1, 2010, Pages 32-40

  Popa Nita, Oana ^a   Naccache, Paul H ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Colchicines; Gout; Inflammation; MSU crystals; Neutrophils; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALGRANULIN A; CALGRANULIN B; COLCHICINE; CORTICOTROPIN[1-39]; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; PICEATANNOL; TERIFLUNOMIDE; URATE; URIC ACID;

ANTIGEN RECOGNITION; CELL INTERACTION; CLINICAL TRIAL; COMPETITIVE INHIBITION; CRYSTAL; GOUT; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MICROTUBULE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; CRYSTALLIZATION; IMMUNOLOGY; METABOLISM;

ANIMALS; CRYSTALLIZATION; GOUT; HUMANS; NEUTROPHIL ACTIVATION; SIGNAL TRANSDUCTION; URIC ACID;

EID: 74249111737     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.98     Document Type: Review

References (119)

1. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.
2. Mandell BF. Clinical manifestations of hyperuricemia and gout. Cleve Clin J Med 2008; 75: S5-S8.
3. Schumacher Jr HR. The pathogenesis of gout. Cleve Clin J Med 2008; 75: S2-S4.
4. Eggebeen AT. Gout: an update. Am Fam Physician 2007; 76: 801-808.
5. Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther 2006; 8: S3.
6. Ortiz-Bravo E, Sieck MS, Schumacher Jr HR. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 1993; 36: 1274-1285.
7. Terkeltaub R, Tenner AJ, Kozin F, Ginsberg MH. Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis. Arthritis Rheum 1983; 26: 775-783.
8. Brandt KD. The effect of synovial hyaluronate on the ingestion of monosodium urate crystals by leukocytes. Clin Chim Acta 1974; 55: 307-315.
9. Terkeltaub R, Curtiss LK, Tenner AJ, Ginsberg MH. Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals. J Clin Invest 1984; 73: 1719-1730.
10. Oehler L, Majdic O, Pickl WF, Stockl J, Riedl E, Drach J et al. Neutrophil granulocytecommitted cells can be driven to acquire dendritic cell characteristics. J Exp Med 1998; 187: 1019-1028.
11. Fanger NA, Liu C, Guyre PM, Wardwell K, O'Neil J, Guo TL et al. Activation of human T cells by major histocompatability complex class II expressing neutrophils: proliferation in the presence of superantigen, but not tetanus toxoid. Blood 1997; 89: 4128-4135.
12. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80: 2012-2020.
13. Landis RC, Yagnik DR, Florey O, Philippidis P, Emons V, Mason JC et al. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002; 46: 3026-3033.
14. Barabe F, Gilbert C, Liao N, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation VI. Involvment of FcgammaRIIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB J 1998; 12: 209-220.
15. Phelps P, McCarty Jr DJ. Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes. J Exp Med 1966; 124: 115-126.
16. Chang YH, Garalla EJ. Suppression of urate crystal-induced canine joint inflammation by heterologous anti-polymorphonuclear leukocyte serum. Arthritis Rheum 1968; 11: 145-150.
17. Becker MA. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout). Rheum Dis Clin North Am 1988; 14: 377-394.
18. Terkeltaub RA, Ginsberg MH. The inflammatory reaction to crystals. Rheum Dis Clin North Am 1988; 14: 353-364.
19. Weissmann G, Rita GA. Molecular basis of gouty inflammation: interaction of monosodium urate crystals with lysosomes and liposomes. Nat New Biol 1972; 240: 167-172.
20. Pekin Jr TJ, Zvaifler NJ. Hemolytic complement in synovial fluid. J Clin Invest 1964; 43: 1372-1382.
21. Tramontini N, Huber C, Liu-Bryan R, Terkeltaub RA, Kilgore KS. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis. Arthritis Rheum 2004; 50: 2633-2639.
22. Ryckman C, Gilbert C, de Medicis R, Lussier A, Vandal K, Tessier PA. Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J Leukoc Biol 2004; 76: 433-440.
23. Jaques BC, Ginsberg MH. The role of cell surface proteins in platelet stimulation by monosodium urate crystals. Arthritis Rheum 1982; 25: 508-521.
24. Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 2006; 177: 6370-6378.
25. Dziarski R, Gupta D. Peptidoglycan recognition in innate immunity. J Endotoxin Res 2005; 11: 304-310.
26. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 2003; 100: 171-194.
27. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005; 174: 5016-5023.
28. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005; 52: 2936-2946.
29. Sendide K, Reiner NE, Lee JS, Bourgoin S, Talal A, Hmama Z. Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 2005; 174: 4210-4219.
30. Gaudry M, Gilbert C, Barabe F, Poubelle PE, Naccache PH. Activation of Lyn is a common element of the stimulation of human neutrophils by soluble and particulate agonists. Blood 1995; 86: 3567-3574.
31. Desaulniers P, Fernandes M, Gilbert C, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals. J Leukoc Biol 2001; 70: 659-668.
32. Popa-Nita O, Proulx S, Pare G, Rollet-Labelle E, Naccache PH. Crystal-induced neutrophil activation: XI. Implication and novel roles of classical protein kinase C. J Immunol 2009; 183: 2104-2114.
33. Gaudry M, Roberge CJ, de Medicis R, Lussier A, Poubelle PE, Naccache PH. Crystalinduced neutrophil activation. III. Inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils. J Clin Invest 1993; 91: 1649-1655.
34. Liu R, Aupperle K, Terkeltaub R. Src family protein tyrosine kinase signaling mediates monosodium urate crystal-induced IL-8 expression by monocytic THP-1 cells. J Leukoc Biol 2001; 70: 961-968.
35. Popa-Nita O, Rollet-Labelle E, Thibault N, Gilbert C, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation. IX. Syk-dependent activation of class Ia phosphatidylinositol 3-kinase. J Leukoc Biol 2007; 82: 763-773.
36. Jackson JK, Lauener R, Duronio V, Burt HM. The involvement of phosphatidylinositol 3-kinase in crystal induced human neutrophil activation. J Rheumatol 1997; 24: 341-348.
37. Hannigan MO, Huang CK, Wu DQ. Roles of PI3K in neutrophil function. Curr Top Microbiol Immunol 2004; 282: 165-175.
38. Popa-Nita O, Marois L, Pare G, Naccache PH. Crystal-induced neutrophil activation: X. Proinflammatory role of the tyrosine kinase Tec. Arthritis Rheum 2008; 58: 1866-1876.
39. Terkeltaub R, Baird S, Sears P, Santiago R, Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum 1998; 41: 900-909.
40. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241.
41. Jones ML, Craik JD, Gibbins JM, Poole AW. Regulation of SHP-1 tyrosine phosphatase in human platelets by serine phosphorylation at its C terminus. J Biol Chem 2004; 279: 40475-40483.
42. Jackon JK, Tudan C, Burt HM. The involvement of phospholipase C in crystal induced human neutrophil activation. J Rheumatol 2000; 27: 2877-2885.
43. Poubelle PE, De Medicis R, Naccache PH. Monosodium urate and calcium pyrophosphate crystals differentially activate the excitation-response coupling sequence of human neutrophils. Biochem Biophys Res Commun 1987; 149: 649-657.
44. Naccache PH, Grimard M, Roberge CJ, Gilbert C, Lussier A, de Medicis R et al. Crystal-induced neutrophil activation. I. Initiation and modulation of calcium mobilization and superoxide production by microcrystals. Arthritis Rheum 1991; 34: 333-342.
45. Flower RJ, Blackwell GJ. The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem Pharmacol 1976; 25: 285-291.
46. Rae SA, Davidson EM, Smith MJ. Leukotriene B4, an inflammatory mediator in gout. Lancet 1982; 2: 1122-1124.
47. Bomalaski JS, Fallon M, Turner RA, Crooke ST, Meunier PC, Clark MA. Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. J Lab Clin Med 1990; 116: 814-825.
48. Bomalaski JS, Baker DG, Brophy LM, Clark MA. Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2-activating protein. J Immunol 1990; 145: 3391-3397.
49. Serhan CN, Lundberg U, Weissmann G, Samuelsson B. Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. Prostaglandins 1984; 27: 563-581.
50. Gilbert C, Poubelle PE, Borgeat P, Pouliot M, Naccache PH. Crystal-induced neutrophil activation: VIII. Immediate production of prostaglandin E2 mediated by constitutive cyclooxygenase 2 in human neutrophils stimulated by urate crystals. Arthritis Rheum 2003; 48: 1137-1148.
51. Marcil J, Harbour D, Houle MG, Naccache PH, Bourgoin S. Monosodium urate-crystalstimulated phospholipase D in human neutrophils. Biochem J 1999; 337(Part 2): 185-192.
52. Liu R, O'Connell M, Johnson K, Pritzker K, Mackman N, Terkeltaub R. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells. Arthritis Rheum 2000; 43: 1145-1155.
53. Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998; 91: 1769-1776.
54. Inokuchi T, Ka T, Yamamoto A, Moriwaki Y, Takahashi S, Tsutsumi Z et al. Effects of ethanol on monosodium urate crystal-induced inflammation. Cytokine 2008; 42: 198-204.
55. Akahoshi T, Namai R, Murakami Y, Watanabe M, Matsui T, Nishimura A et al. Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 2003; 48: 231-239.
56. Ogura Y, Sutterwala FS, Flavell RA. The inflammasome: first line of the immune response to cell stress. Cell 2006; 126: 659-662.
57. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-426.
58. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003; 4: 95-104.
59. Roberge CJ, Grassi J, De Medicis R, Frobert Y, Lussier A, Naccache PH et al. Crystal-neutrophil interactions lead to interleukin-1 synthesis. Agents Actions 1991; 34: 38-41.
60. Roberge CJ, de Medicis R, Dayer JM, Rola-Pleszczynski M, Naccache PH, Poubelle PE. Crystal-induced neutrophil activation. V. Differential production of biologically active IL-1 and IL-1 receptor antagonist. J Immunol 1994; 152: 5485-5494.
61. Ginsberg MH, Kozin F, Chow D, May J, Skosey JL. Adsorption of polymorphonuclear leukocyte lysosomal enzymes to monosodium urate crystals. Arthritis Rheum 1977; 20: 1538-1542.
62. Abramson S, Hoffstein ST, Weissmann G. Superoxide anion generation by human neutrophils exposed to monosodium urate. Arthritis Rheum 1982; 25: 174-180.
63. Hachicha M, Naccache PH, McColl SR. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 1995; 182: 2019-2025.
64. Spilberg I, Mandell B, Wochner RD. Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity. J Lab Clin Med 1974; 83: 56-63.
65. Desaulniers P, Marois S, Pare G, Popa-Nita O, Gilbert C, Naccache PH. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals. J Rheumatol 2006; 33: 928-938.
66. Schumacher HR, Fishbein P, Phelps P, Tse R, Krauser R. Comparison of sodium urate and calcium pyrophosphate crystal phagocytosis by polymorphonuclear leukocytes. Effects of crystal size and other factors. Arthritis Rheum 1975; 18: 783-792.
67. Shirahama T, Cohen AS. Ultrastructural evidence for leakage of lysosomal contents after phagocytosis of monosodium urate crystals. A mechanism of gouty inflammation. Am J Pathol 1974; 76: 501-520.
68. Tudan C, Jackson JK, Blanis L, Pelech SL, Burt HM. Inhibition of TNF-alpha-induced neutrophil apoptosis by crystals of calcium pyrophosphate dihydrate is mediated by the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways up-stream of caspase 3. J Immunol 2000; 165: 5798-5806.
69. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003; 24: 155-158.
70. Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, Poubelle PE et al. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 2003; 48: 2310-2320.
71. Wigley FM, Fine IT, Newcombe DS. The role of the human synovial fibroblast in monosodium urate crystal-induced synovitis. J Rheumatol 1983; 10: 602-611.
72. Weissmann G, Smolen JE, Korchak H. Prostaglandins and inflammation: receptor/ cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells. Adv Prostaglandin Thromboxane Res 1980; 8: 1637-1653.
73. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 2004; 25: 40-46.
74. van Der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. Prostaglandin- E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995; 181: 775-779.
75. Hilkens C, Snijders A, Vermeulen H, van Der Meide P, Wierenga E, Kapsenberg M. Accessory cell-derived interleukin-12 and prostaglandin E2 determine the level of interferon-gamma produced by activated human CD4+ T cells. Ann N Y Acad Sci 1996; 795: 349-350. (Pubitemid 27029588)
76. Takayama K, Garcia-Cardena G, Sukhova GK, Comander J, Gimbrone Jr MA. Libby P Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002; 277: 44147-44154.
77. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006; 116: 2262-2271.
78. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007; 9: R28.
79. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 2003; 284: L566-L577.
80. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocytederived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystalinduced inflammation. Arthritis Rheum 1991; 34: 894-903.
81. Phelps P, Andrews R, Rosenbloom J. Demonstration of chemotactic factor in human gout: further characterization of occurrence and structure. J Rheumatol 1981; 8: 889-894.
82. Bhatt AK, Spilberg I. Purification of crystal induced chemotactic factor from human neutrophils. Clin Biochem 1988; 21: 341-345.
83. Schumacher HR. Crystal-induced arthritis: an overview. Am J Med 1996; 100: 46S-52S.
84. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med 2005; 143: 499-516.
85. Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004; 50: 2273-2280.
86. Liote F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E et al. Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 1996; 39: 1192-1198.
87. Shen L, Smith JM, Shen Z, Eriksson M, Sentman C, Wira CR. Inhibition of human neutrophil degranulation by transforming growth factor-beta1. Clin Exp Immunol 2007; 149: 155-161.
88. Louthrenoo W, Sieck M, Clayburne G, Rothfuss S, Schumacher Jr HR. Supravital staining of cells in noninflammatory synovial fluids: analysis of the effect of crystals on cell populations. J Rheumatol 1991; 18: 409-413.
89. Pascual E, Jovani V. A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout. Br J Rheumatol 1995; 34: 724-726.
90. Di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991; 87: 1375-1381.
91. Di Giovine FS, Malawista SE, Nuki G, Duff GW. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 1987; 138: 3213-3218.
92. Guerne PA, Terkeltaub R, Zuraw B, Lotz M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989; 32: 1443-1452.
93. Chapman PT, Yarwood H, Harrison AA, Stocker CJ, Jamar F, Gundel RH et al. Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis Rheum 1997; 40: 955-965.
94. Yagnik DR, Hillyer P, Marshall D, Smythe CD, Krausz T, Haskard DO et al. Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum 2000; 43: 1779-1789.
95. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405: 421-424.
96. Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000; 106: 189-197.
97. Ricote M, Huang JT, Welch JS, Glass CK. The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol 1999; 66: 733-739.
98. Lipton JM, Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha- MSH. Immunol Today 1997; 18: 140-145.
99. O'Donohue TL, Dorsa DM. The opiomelanotropinergic neuronal and endocrine systems. Peptides 1982; 3: 353-395.
100. Ritter J, Kerr LD, Valeriano-Marcet J, Spiera H. ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J Rheumatol 1994; 21: 696-699.
101. Getting SJ, Christian HC, Flower RJ, Perretti M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 2002; 46: 2765-2775.
102. Getting SJ, Lam CW, Chen AS, Grieco P, Perretti M. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J 2006; 20: 2234-2241.
103. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83: 865-875.
104. Margolis RL, Wilson L. Addition of colchicine-tubulin complex to microtubule ends: the mechanism of substoichiometric colchicine poisoning. Proc Natl Acad Sci USA 1977; 74: 3466-3470.
105. Zemer D, Pras M, Sohar E, Gafni J. Letter: Colchicine in Familial Mediterranean fever. N Engl J Med 1976; 294: 170-171.
106. Matsumura N, Mizushima Y. Leucocyte movement and colchicine treatment in Behcet's disease. Lancet 1975; 2: 813.
107. Franklin EC. Amyloidosis. Bull Rheum Dis 1975; 26: 832-837.
108. Housset E. Efficacy of certain derivatives of colchicine in the treatment of sclerodermic syndromes. Angeiologie 1964; 16: 23.
109. Markel G, Imazio M, Brucato A, Adler Y. Colchicine for the prevention of recurrent pericarditis. Isr Med Assoc J 2008; 10: 69-72.
110. Bane SL, Ravindra R, Zaydman AA. High-throughput screening of microtubuleinteracting drugs. Methods Mol Med 2007; 137: 281-288.
111. Phelps P. Polymorphonuclear leukocyte motility in vitro. II. Stimulatory effect of monosodium urate crystals and urate in solution; partial inhibition by colchicine and indomethacin. Arthritis Rheum 1969; 12: 189-196.
112. Dallaverde E, Fan PT, Chang YH. Mechanism of action of colchicine. V. Neutrophil adherence and phagocytosis in patients with acute gout treated with colchicine. J Pharmacol Exp Ther 1982; 223: 197-202.
113. Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystalinduced rabbit arthritis. Lab Invest 1998; 78: 559-569.
114. Pike MC, Kredich NM, Snyderman R. Influence of cytoskeletal assembly on phosphatidylcholine synthesis in intact phagocytic cells. Cell 1980; 20: 373-379.
115. Roberge CJ, Gaudry M, de Medicis R, Lussier A, Poubelle PE, Naccache PH. Crystalinduced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine. J Clin Invest 1993; 92: 1722-1729.
116. Roberge CJ, Gaudry M, Gilbert C, Malawista SE, de Medicis R, Lussier A et al. Paradoxical effects of colchicine on the activation of human neutrophilis by chemotactic factors and inflammatory microcrystal. J Leukoc Biol 1996; 59: 864-871.
117. Matten WT, Aubry M, West J, Maness PF. Tubulin is phosphorylated at tyrosine by pp60c-src in nerve growth cone membranes. J Cell Biol 1990; 111(5 Part 1): 1959-1970.
118. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G. Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 1998; 111(Part 21): 3167-3177.
119. Draberova L, Draberova E, Surviladze Z, Draber P. Protein tyrosine kinase p53/ p56(lyn) forms complexes with gamma-tubulin in rat basophilic leukemia cells. Int Immunol 1999; 11: 1829-1839.